Phase 2CompletedAge-related condition

The Menopause After Cancer Study (MACS)

A Multimodal Technology-assisted Intervention for the Management of Menopause After Cancer: The Menopause After Cancer Study

Sponsor
University College Dublin (Academic or other)
Enrollment
205 enrolled
Conditions
Menopause; Cancer; Insomnia
Interventions
Citalopram +/- Gabapentin + Sleepio + support person
Ages
adults, older adults
Registry
NCT04766229

Full record on ClinicalTrials.gov

From the registry

This study will recruit women with vasomotor symptoms of menopause and a prior cancer diagnosis, for whom conventional menopausal hormone therapy (MHT) is contraindicated for any reason. This study will examine if the addition of psycho-social support and digital cognitive behavioral therapy (CBT) for insomnia to standard non-hormonal pharmacotherapy can improve quality of life for these women.

Primary outcomes

  • Global Quality of Life scores as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ C30) instrument

History

  1. Last registry update

  2. Primary completion

  3. Started

  4. Registered

Papers citing this trial